FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Lewis

Research Profile

Chemicals & Drugs

Concepts & Ideas

Tissue Distribution

Anatomy

Tumor Cell Line

Living Beings

Procedures

Co-author Network

Publications

TOP 3
Kimberly A Statham-Ringen; Kim A Selting; Jeffrey N Bryan; Jonathan A Green; Carolyn J Henry; Fang Jia; Jimmy C Lattimer; Michael R Lewis
Evaluation of a B-cell leukemia-lymphoma 2-specific radiolabeled peptide nucleic acid-peptide conjugate for scintigraphic detection of neoplastic lymphocytes in dogs with B-cell lymphoma.
Michael R Lewis
Looking through the vascular normalization window: timing antiangiogenic treatment and chemotherapy with (99m)Tc-annexin A5.
Ethan R Balkin; Fang Jia; William H Miller; Michael R Lewis
In vitro evaluation of targeted antisense 177Lu radiotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Lewis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Kimberly A Statham-Ringen; Kim A Selting; Jeffrey N Bryan; Jonathan A Green; Carolyn J Henry; Fang Jia; Jimmy C Lattimer; Michael R Lewis
Evaluation of a B-cell leukemia-lymphoma 2-specific radiolabeled peptide nucleic acid-peptide conjugate for scintigraphic detection of neoplastic lymphocytes in dogs with B-cell lymphoma.
American journal of veterinary research 2012;73(5):681-8.
2011: Michael R Lewis
Looking through the vascular normalization window: timing antiangiogenic treatment and chemotherapy with (99m)Tc-annexin A5.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(11):1670-2.
2011: Ethan R Balkin; Fang Jia; William H Miller; Michael R Lewis
In vitro evaluation of targeted antisense 177Lu radiotherapy.
Anticancer research 2011;31(10):3143-9.
2011: Jeffrey N Bryan; Carolyn J Henry; Fang Jia; William H Miller; Huma Mohsin; Geethapriya Sivaguru; Carolyn J Anderson; Michael R Lewis
Monoclonal antibodies for copper-64 PET dosimetry and radioimmunotherapy.
Cancer biology & therapy 2011;11(12):1001-7.
2011: Heather M Bigott-Hennkens; Shorouk F Dannoon; Samantha M Noll; Varyanna C Ruthengael; Silvia S Jurisson; Michael R Lewis
Labeling, stability and biodistribution studies of 99mTc-cyclized Tyr3-octreotate derivatives.
Nuclear medicine and biology 2011;38(4):549-55.
2010: Shorouk F Dannoon; Heather M Bigott-Hennkens; Lixin Ma; Fabio Gallazzi; Michael R Lewis; Silvia S Jurisson
In vitro structure-activity relationship of Re-cyclized octreotide analogues.
Nuclear medicine and biology 2010;37(5):527-37.
2009: Jeffrey N Bryan; Mohamed Jabbes; Linda M Berent; Gerald L Arthur; Kristen H Taylor; Kerry C Rissetto; Carolyn J Henry; Farahnaz Rahmatpanah; Wendi V Rankin; Jose A Villamil; Michael R Lewis; Charles Caldwell
Hypermethylation of the DLC1 CpG island does not alter gene expression in canine lymphoma.
BMC genetics 2009;10():73.
2008: H M Bigott-Hennkens; S Dannoon; Michael R Lewis; Silvia S Jurisson
In vitro receptor binding assays: general methods and considerations.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2008;52(3):245-53.
2008: Juri Ota; Elizabeth A Giuliano; L A Cohn; Michael R Lewis; Cecil P Moore
Local photodynamic therapy for equine squamous cell carcinoma: evaluation of a novel treatment method in a murine model.
Veterinary journal (London, England : 1997) 2008;176(2):170-6.
2008: Heather M Bigott-Hennkens; Sulochana Junnotula; Lixin Ma; Fabio Gallazzi; Michael R Lewis; Silvia S Jurisson
Synthesis and in vitro evaluation of a rhenium-cyclized somatostatin derivative series.
Journal of medicinal chemistry 2008;51(5):1223-30.
2008: Fang Jia; Said Daibes Figueroa; Fabio Gallazzi; Baghavathy Balaji; Mark Hannink; Susan Z Lever; Timothy Hoffman; Michael R Lewis
Molecular imaging of bcl-2 expression in small lymphocytic lymphoma using 111In-labeled PNA-peptide conjugates.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(3):430-8.
2008: Stephanie C Essman; Michael R Lewis; Derek B Fox
Effects of increasing doses of samarium-153-ethylenediaminetetramethylene phosphonate on axial and appendicular skeletal growth in juvenile rabbits.
Nuclear medicine and biology 2008;35(2):219-25.
2007: Fang Jia; Tiffani Shelton; Michael R Lewis
Preparation, characterization, and biological evaluation of a streptavidin-chimeric t84.66 conjugate for antibody pretargeting.
Cancer biotherapy & radiopharmaceuticals 2007;22(5):654-64.
2007: Adam Prasanphanich; Prasant K Nanda; Tammy L Rold; Lixin Ma; Michael R Lewis; Jered C Garrison; Timothy Hoffman; Gary L Sieckman; Said Daibes Figueroa; Charles J Smith
[64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(30):12462-7.
2007: Huma Mohsin; Jonathan Fitzsimmons; Tiffani Shelton; Timothy Hoffman; Cathy S Cutler; Michael R Lewis; Phillip S Athey; Gyongyi Gulyas; Garry E Kiefer; R Keith Frank; Jaime Simon; Susan Z Lever; Silvia S Jurisson
Preparation and biological evaluation of 111In-, 177Lu- and 90Y-labeled DOTA analogues conjugated to B72.3.
Nuclear medicine and biology 2007;34(5):493-502.
2006: Baghavathy Balaji; Fabio Gallazzi; Fang Jia; Michael R Lewis
An efficient, convenient solid-phase synthesis of amino acid-modified peptide nucleic acid monomers and oligomers.
Bioconjugate chemistry 2006;17(2):551-8.
2006: Huma Mohsin; Fang Jia; Geethapriya Sivaguru; Michael J Hudson; Tiffani Shelton; Timothy Hoffman; Cathy S Cutler; Alan R Ketring; Phillip S Athey; Jaime Simón; R Keith Frank; Silvia S Jurisson; Michael R Lewis
Radiolanthanide-labeled monoclonal antibody CC49 for radioimmunotherapy of cancer: biological comparison of DOTA conjugates and 149Pm, 166Ho, and 177Lu.
Bioconjugate chemistry 2006;17(2):485-92.
2006: Michael R Lewis
A "new" reporter in the field of imaging reporter genes: correlating gene expression and function of the sodium/iodide symporter.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(1):1-3.
2005: Stephanie C Essman; Michael R Lewis; William H Miller
Intraorgan biodistribution and dosimetry of 153Sm-ethylenediaminetetramethylene phosphonate in juvenile rabbit tibia: implications for targeted radiotherapy of osteosarcoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(12):2076-82.
2005: Jeffrey N Bryan; Fang Jia; Huma Mohsin; Geethapriya Sivaguru; William H Miller; Carolyn J Anderson; Carolyn J Henry; Michael R Lewis
Comparative uptakes and biodistributions of internalizing vs. noninternalizing copper-64 radioimmunoconjugates in cell and animal models of colon cancer.
Nuclear medicine and biology 2005;32(8):851-8.
2005: William H Miller; Christine Hartmann Siantar; Darrell Fisher; Marie-Anne Descalle; Thomas P Daly; Joerg Lehmann; Michael R Lewis; Timothy Hoffman; Jeff Smith; Peter D Situ; Wynn A Volkert
Evaluation of beta-absorbed fractions in a mouse model for 90Y, 188Re, 166Ho, 149Pm, 64Cu, and 177Lu radionuclides.
Cancer biotherapy & radiopharmaceuticals 2005;20(4):436-49.
2005: Michael R Lewis
Radiolabeled RGD peptides move beyond cancer: PET imaging of delayed-type hypersensitivity reaction.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(1):2-4.
2004: Jeffrey N Bryan; Michael R Lewis; Carolyn J Henry; Nellie K Owen; Jiuli Zhang; Huma Mohsin; Fang Jia; G Sivaguru; Carolyn J Anderson
Development of a two-antibody model for the evaluation of copper-64 radioimmunotherapy.
Veterinary and comparative oncology 2004;2(2):82-90.
2004: Michael R Lewis; Jiuli Zhang; Fang Jia; Nellie K Owen; Cathy S Cutler; Mary F Embree; Jody Schultz; Louis J Theodore; Alan R Ketring; Silvia S Jurisson; Axworthy Don
Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude mice.
Nuclear medicine and biology 2004;31(2):213-23.
2003: Fabio Gallazzi; Yi Wang; Fang Jia; Nalini Shenoy; Linda A Landon; Mark Hannink; Susan Z Lever; Michael R Lewis
Synthesis of radiometal-labeled and fluorescent cell-permeating peptide-PNA conjugates for targeting the bcl-2 proto-oncogene.
Bioconjugate chemistry 2003;14(6):1083-95.
2003: Mu Wang; Amy L Caruano; Michael R Lewis; Laura A Meyer; Robert Peter Vander Waal; Carolyn J Anderson
Subcellular localization of radiolabeled somatostatin analogues: implications for targeted radiotherapy of cancer.
Cancer research 2003;63(20):6864-9.
2003: Michael R Lewis; Fang Jia
Antisense imaging: and miles to go before we sleep?
Journal of cellular biochemistry 2003;90(3):464-72.
2003: Carla J Mathias; Michael R Lewis; David E Reichert; Richard Laforest; Terry L Sharp; Jason S Lewis; Zhen Fan Yang; David J Waters; Paul W Snyder; Philip S Low; Michael J Welch; Mark A Green
Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals.
Nuclear medicine and biology 2003;30(7):725-31.
2003: Michael R Lewis; Mu Wang; Axworthy Don; Louis J Theodore; Robert W Mallet; Alan R Fritzberg; Michael J Welch; Carolyn J Anderson
In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(8):1284-92.
2002: Michael R Lewis; Fang Jia; Fabio Gallazzi; Yi Wang; Jiuli Zhang; Nalini Shenoy; Susan Z Lever; Mark Hannink
Radiometal-labeled peptide-PNA conjugates for targeting bcl-2 expression: preparation, characterization, and in vitro mRNA binding.
Bioconjugate chemistry 2002;13(6):1176-80.
2002: Michael R Lewis; David E Reichert; Richard Laforest; William H Margenau; Ruth E Shefer; Robert E Klinkowstein; Barbara J Hughey; Michael J Welch
Production and purification of gallium-66 for preparation of tumor-targeting radiopharmaceuticals.
Nuclear medicine and biology 2002;29(6):701-6.
2001: Michael R Lewis; C Andrew Boswell; Richard Laforest; Thomas L Buettner; D Ye; Judith M Connett; Carolyn J Anderson
Conjugation of monoclonal antibodies with TETA using activated esters: biological comparison of 64Cu-TETA-1A3 with 64Cu-BAT-2IT-1A3.
Cancer biotherapy & radiopharmaceuticals 2001;16(6):483-94.
2000: Jason S Lewis; Richard Laforest; Michael R Lewis; Carolyn J Anderson
Comparative dosimetry of copper-64 and yttrium-90-labeled somatostatin analogs in a tumor-bearing rat model.
Cancer biotherapy & radiopharmaceuticals 2000;15(6):593-604.
1999: Jason S Lewis; Michael R Lewis; PD Cutler; Ananth Srinivasan; Michelle A Schmidt; Sally W Schwarz; M M Morris; Philip Miller; Carolyn J Anderson
Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(11):3608-16.